腎除神経の市場規模、シェア、成長分析、製品別、技術別、エンドユーザー別、地域別-産業予測、2025～2032年

腎除神経の世界市場規模は2023年に4億3,364万米ドルとなり、2024年の6億1,013万米ドルから2032年には 93億7,079万米ドルに成長し、予測期間（2025～2032年）のCAGRは40.7%で推移する見通しです。

腎除神経の世界市場は、高血圧の有病率の上昇と、低侵襲治療としての腎除神経の利点に対する認識の高まりによって、力強い成長を遂げています。この治療法は、腎神経を効果的に遮断して血圧を調整するもので、薬物への依存を減らし、患者の予後を改善する可能性があることから、患者や医療提供者にとって魅力的です。高周波や超音波エネルギーを利用した革新的なカテーテルシステムなどの技術的進歩により、手技の精度と安全性が向上し、導入がさらに促進されています。しかし、有効性を検証するための長期的な臨床データの必要性や保険償還の障壁など、課題も残っています。このような障害にもかかわらず、腎除神経市場は継続的な拡大が見込まれており、効果的な高血圧治療に対する需要の高まりとともに、医療機器イノベーターに有望な機会を提供しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• ケーススタディ
• 技術の進歩

腎除神経の市場規模：製品別& CAGR（2025-2032）

• 市場概要
• シンプリシティ
• ベシックス（V2）
• エンライトン
• パラダイス
• イベリス
• その他

腎除神経の市場規模：技術別& CAGR（2025-2032）

• 市場概要
• 無線周波数
• 超音波
• マイクロインフュージョン
• その他

腎除神経の市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 病院
• クリニック
• 外来手術センター
• その他

腎除神経の市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Medtronic（Ireland）
• Symap Medical（China）
• Shanghai Golden Leaf Medtec（China）
• Shanghai Wisegain Medical Devices（China）
• Terumo Corporation（Japan）
• Abbott Laboratories（USA）
• Johnson & Johnson（USA）
• Boston Scientific（USA）
• St. Jude Medical（USA）
• Cordis Corporation（USA）
• Vessix Vascular（USA）
• Ardian（USA）
• Otsuka Holdings（Japan）

結論と推奨事項

Global Renal Denervation Market size was valued at USD 433.64 million in 2023 and is poised to grow from USD 610.13 million in 2024 to USD 9370.79 million by 2032, growing at a CAGR of 40.7% during the forecast period (2025-2032).

The global renal denervation market is experiencing robust growth, driven by the rising prevalence of hypertension and increasing awareness of renal denervation's benefits as a minimally invasive treatment. This procedure effectively disrupts renal nerves to regulate blood pressure, appealing to patients and healthcare providers alike due to its potential to reduce dependence on medications and enhance patient outcomes. Technological advancements, including innovative catheter systems utilizing radiofrequency or ultrasound energy, have improved the procedure's precision and safety, further promoting adoption. However, challenges remain, such as the need for more long-term clinical data to validate efficacy and reimbursement barriers. Despite these obstacles, the renal denervation market is poised for continued expansion, offering lucrative opportunities for medical device innovators as demand for effective hypertension treatments grows.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Renal Denervation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Renal Denervation Market Segmental Analysis

Global Renal Denervation Market is segmented by product, technology, end-users and region. Based on product, the market is segmented into simplicity, vessix (V2), enlightn, paradise, iberis and others. Based on technology, the market is segmented into radiofrequency, ultrasound, micro-infusion and others. Based on end-users, the market is segmented into hospital, clinics, ambulatory surgery centers and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Renal Denervation Market

The Global Renal Denervation market is significantly propelled by technological advancements that enhance the effectiveness and safety of the procedure. Innovations in catheter designs, enhanced energy delivery systems, and the development of novel nerve-modifying agents are all contributing to this growth. These improvements not only increase the precision of renal denervation but also expand its clinical applications, leading to better patient outcomes. As these technologies continue to evolve, they are making renal denervation a more viable treatment option for patients with resistant hypertension, ultimately driving greater adoption and expansion of this market on a global scale.

Restraints in the Global Renal Denervation Market

The Global Renal Denervation market faces several restraints, particularly due to limited awareness and adoption in emerging markets. In these regions, the understanding of renal denervation as a viable treatment for hypertension is often minimal, which hinders its acceptance among both healthcare providers and patients. Furthermore, inadequate healthcare infrastructure exacerbates this issue, restricting access to advanced medical treatments and technologies. As a result, the growth potential of the renal denervation market in these areas is significantly constrained, as efforts to educate stakeholders and improve healthcare services are still underway. These challenges must be addressed to facilitate market expansion.

Market Trends of the Global Renal Denervation Market

The Global Renal Denervation market is witnessing a significant shift towards ambulatory settings, where procedures are increasingly performed on an outpatient basis rather than in traditional hospital environments. This trend is propelled by the dual benefits of cost-effectiveness and patient convenience, as outpatient procedures reduce hospitalization times and associated costs. Enhanced accessibility to renal denervation techniques in ambulatory settings not only democratizes patient care but also stimulates market growth by attracting a broader patient demographic seeking less invasive treatment options. As healthcare systems evolve and prioritize outpatient care, this trend is poised to reshape the landscape of renal denervation therapies globally.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Renal Denervation Market Size by Product & CAGR (2025-2032)

• Market Overview
• Simplicity
• Vessix (V2)
• Enlightn
• Paradise
• Iberis
• Others

Global Renal Denervation Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Radiofrequency
• Ultrasound
• Micro-Infusion
• Others

Global Renal Denervation Market Size by End-Users & CAGR (2025-2032)

• Market Overview
• Hospital
• Clinics
• Ambulatory Surgery Centers
• Others

Global Renal Denervation Market Size & CAGR (2025-2032)

• North America (Product, Technology, End-Users)
  • US
  • Canada
• Europe (Product, Technology, End-Users)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, End-Users)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, End-Users)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, End-Users)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Symap Medical (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai Golden Leaf Medtec (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai Wisegain Medical Devices (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• St. Jude Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cordis Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vessix Vascular (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ardian (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Otsuka Holdings (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations